Open Beta
TREN
MetriLume
TREN

US marketsKPHMW

SEC-sourced researchBeta

KPHMW

KIORA PHARMACEUTICALS INC

Company comparison ↗

Data passport

CIK
0001372514
Exchange
OTC
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 17, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 16,020,000.0000 USD; December 2025: 0.0000 USD16M USD0 USD0December 2024December 2025
KPHMW · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202416,020,000.0000Mar 25, 2026
December 20250.0000Mar 25, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20250.0000-10,835,154.0000-9,961,176.000024,253,300.00008,126,764.0000Mar 25, 2026
December 202416,020,000.00003,594,733.00008,559,115.000036,484,484.000010,724,708.0000Mar 25, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$0December 2025Mar 25, 202610-K
Previous period revenueRevenues$16.02MDecember 2024Mar 25, 202610-K
Net incomeNetIncomeLoss-$10.84MDecember 2025Mar 25, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$9.96MDecember 2025Mar 25, 202610-K
Total assetsAssets$24.25MDecember 2025Mar 25, 202610-K
Total liabilitiesLiabilities$8.13MDecember 2025Mar 25, 202610-K

New filings

Explore methodology ↗